July 10, 2008 - A novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), has been approved for marketing in South Korea, representing the 34th country in which the agent has been approved, reported the manufacturer EPIX Pharmaceuticals Inc.
